BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33783548)

  • 21. Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity.
    Zhitomirsky B; Yunaev A; Kreiserman R; Kaplan A; Stark M; Assaraf YG
    Cell Death Dis; 2018 Dec; 9(12):1191. PubMed ID: 30546014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma.
    Goodman VL; Rock EP; Dagher R; Ramchandani RP; Abraham S; Gobburu JV; Booth BP; Verbois SL; Morse DE; Liang CY; Chidambaram N; Jiang JX; Tang S; Mahjoob K; Justice R; Pazdur R
    Clin Cancer Res; 2007 Mar; 13(5):1367-73. PubMed ID: 17332278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Lysosomal Sequestration of Tyrosine Kinase Inhibitors and Drug Resistance.
    Ruzickova E; Skoupa N; Dolezel P; Smith DA; Mlejnek P
    Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31683643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-World Evidence of Patient Outcome Following Treatment of Advanced Gastrointestinal Stromal Tumor (GIST) with Imatinib, Sunitinib, and Sorafenib in Publicly Funded Health Care in Poland.
    Brzozowska M; Wierzba W; Szafraniec-Buryło S; Czech M; Połowinczak-Przybyłek J; Potemski P; Śliwczyński A
    Med Sci Monit; 2019 May; 25():3846-3853. PubMed ID: 31121600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Docetaxel enhances lysosomal function through TFEB activation.
    Zhang J; Wang J; Wong YK; Sun X; Chen Y; Wang L; Yang L; Lu L; Shen HM; Huang D
    Cell Death Dis; 2018 May; 9(6):614. PubMed ID: 29795139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 6-Hydroxydopamine induces autophagic flux dysfunction by impairing transcription factor EB activation and lysosomal function in dopaminergic neurons and SH-SY5Y cells.
    He X; Yuan W; Li Z; Hou Y; Liu F; Feng J
    Toxicol Lett; 2018 Feb; 283():58-68. PubMed ID: 29170033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysosomal membrane glycoproteins bind cholesterol and contribute to lysosomal cholesterol export.
    Li J; Pfeffer SR
    Elife; 2016 Sep; 5():. PubMed ID: 27664420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetics and treatment of gastrointestinal stromal tumors with immune checkpoint inhibitors: what do we know?
    Indio V; Astolfi A; Urbini M; Nannini M; Pantaleo MA
    Pharmacogenomics; 2020 Mar; 21(4):231-234. PubMed ID: 31973655
    [No Abstract]   [Full Text] [Related]  

  • 29. Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib.
    Janeway KA; Albritton KH; Van Den Abbeele AD; D'Amato GZ; Pedrazzoli P; Siena S; Picus J; Butrynski JE; Schlemmer M; Heinrich MC; Demetri GD
    Pediatr Blood Cancer; 2009 Jul; 52(7):767-71. PubMed ID: 19326424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A stress response p38 MAP kinase inhibitor SB202190 promoted TFEB/TFE3-dependent autophagy and lysosomal biogenesis independent of p38.
    Yang C; Zhu Z; Tong BC; Iyaswamy A; Xie WJ; Zhu Y; Sreenivasmurthy SG; Senthilkumar K; Cheung KH; Song JX; Zhang HJ; Li M
    Redox Biol; 2020 May; 32():101445. PubMed ID: 32037305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imatinib escalation or sunitinib treatment after first-line imatinib in metastatic gastrointestinal stromal tumor patients.
    Hsu CC; Wu CE; Chen JS; Tseng JH; Chiang KC; Liu YY; Tsai CY; Cheng CT; Chen TW; Jan YY; Yeh TS; Chen YY; Yeh CN
    Anticancer Res; 2014 Sep; 34(9):5029-36. PubMed ID: 25202087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autophagy dysregulation in Danon disease.
    Nascimbeni AC; Fanin M; Angelini C; Sandri M
    Cell Death Dis; 2017 Jan; 8(1):e2565. PubMed ID: 28102838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastrointestinal stromal tumor - A review of clinical studies.
    Khoshnood A
    J Oncol Pharm Pract; 2019 Sep; 25(6):1473-1485. PubMed ID: 31068088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The tumor suppressor p53 regulates autophagosomal and lysosomal biogenesis in lung cancer cells by targeting transcription factor EB.
    Zhang Z; Wang H; Ding Q; Xing Y; Xu D; Xu Z; Zhou T; Qian B; Ji C; Pan X; Zhong A; Ying Z; Zhou C; Shi M
    Biomed Pharmacother; 2017 May; 89():1055-1060. PubMed ID: 28292013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysosome-associated membrane proteins h-LAMP1 (CD107a) and h-LAMP2 (CD107b) are activation-dependent cell surface glycoproteins in human peripheral blood mononuclear cells which mediate cell adhesion to vascular endothelium.
    Kannan K; Stewart RM; Bounds W; Carlsson SR; Fukuda M; Betzing KW; Holcombe RF
    Cell Immunol; 1996 Jul; 171(1):10-9. PubMed ID: 8660832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blue light-emitting diode irradiation promotes transcription factor EB-mediated lysosome biogenesis and lysosomal cell death in murine photoreceptor-derived cells.
    Otsu W; Ishida K; Nakamura S; Shimazawa M; Tsusaki H; Hara H
    Biochem Biophys Res Commun; 2020 May; 526(2):479-484. PubMed ID: 32234235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cu(II) disrupts autophagy-mediated lysosomal degradation of oligomeric Aβ in microglia via mTOR-TFEB pathway.
    Tan X; Guan H; Yang Y; Luo S; Hou L; Chen H; Li J
    Toxicol Appl Pharmacol; 2020 Aug; 401():115090. PubMed ID: 32512069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib.
    Schuetze SM; Bolejack V; Thomas DG; von Mehren M; Patel S; Samuels B; Choy E; D'Amato G; Staddon AP; Ganjoo KN; Chow WA; Rushing DA; Forscher CA; Priebat DA; Loeb DM; Chugh R; Okuno S; Reinke DK; Baker LH
    JAMA Oncol; 2018 Jun; 4(6):814-820. PubMed ID: 29710216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Giant Cellular Vacuoles Induced by Rare Earth Oxide Nanoparticles are Abnormally Enlarged Endo/Lysosomes and Promote mTOR-Dependent TFEB Nucleus Translocation.
    Lin J; Shi SS; Zhang JQ; Zhang YJ; Zhang L; Liu Y; Jin PP; Wei PF; Shi RH; Zhou W; Wen LP
    Small; 2016 Nov; 12(41):5759-5768. PubMed ID: 27593892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptome profiling analysis reveals that ATP6V0E2 is involved in the lysosomal activation by anlotinib.
    Sun X; Shu Y; Yan P; Huang H; Gao R; Xu M; Lu L; Tian J; Huang D; Zhang J
    Cell Death Dis; 2020 Aug; 11(8):702. PubMed ID: 32839434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.